Author: John Meady

Stock Movers

Why Ampio Pharmaceuticals (NYSEMKT:AMPE) Shares are Dropping This Morning

Shares of Ampio Pharmaceuticals (NYSEMKT:AMPE) fell in Friday’s pre-market session, after the biopharmaceutical company priced a public offering of 8.5 million shares at $7 per share, a 12% discount to the stock’s Thursday closing price. The shares were off 6.2% at $7.45 in recent pre-market trading. They have a 52-week range of $3.75 to $10.86. Net proceeds of the offering are expected to be approximately … Continue reading Why Ampio Pharmaceuticals (NYSEMKT:AMPE) Shares are Dropping This Morning

John Meady
Earnings, Stock Movers

Pre-Market Watchlist: DRQ, CGEN, OVTI, BVN, AMAP

Dril-Quip, Inc. (NYSE:DRQ), which makes engineered offshore drilling and production equipment, said net income rose to $47.1 million, or $1.15 per diluted share, from $31.0 million, or $0.76 per diluted share, beating analysts’ estimates by one cent, according to Capital IQ. The company said the Q4 results for 2013 results were hit by an after-tax foreign exchange loss of $2.3 million, or $0.06 per diluted … Continue reading Pre-Market Watchlist: DRQ, CGEN, OVTI, BVN, AMAP

John Meady
Analysis, Consumer Goods

Thursday Market Movers: J.C. Penney Company, Inc. (NYSE:JCP), Mylan (NASDAQ:MYL)

Shares of J.C. Penney Company, Inc. (NYSE:JCP) have soared almost 27% in pre-market trade to $7.55 after the company reported Q4 results during yesterday’s after-hours session that topped analyst expectations. JCP reported earnings per share losses of $0.68 for the quarter, compared to analyst forecasts of losses of $0.76 per share. The retailer also reported Q4 net income of $35 million, or $0.11 per share, … Continue reading Thursday Market Movers: J.C. Penney Company, Inc. (NYSE:JCP), Mylan (NASDAQ:MYL)

John Meady
BioTech, business, Finance, Financial, misc, news

Earnings Watch: HII, WEN, RBS, IRM, KBR, NRG

Huntington Ingalls Industries (NYSE:HII) reported Q4 earnings that were well ahead of analysts’ estimates. The ship- and submarine builder said its adjusted diluted earnings rose nearly 28% to $1.66, exceeding the $1.22 average estimate from analysts polled by Capital IQ, if comparable. On a non-adjusted basis, diluted net earnings rose to $91 million from $50 million. Sales in the quarter meanwhile rose 6.2% to $1.94 … Continue reading Earnings Watch: HII, WEN, RBS, IRM, KBR, NRG

John Meady
Analysis, Earnings

Tower Semiconductor (NASDAQ:TSEM) Tops Street Forecasts; NYSE:TSL, NYSE:DE, NYSE:KSS

Specialty foundry company Tower Semiconductor Ltd. (NASDAQ:TSEM) reports non-GAAP diluted EPS of $0.34 for Q4 2013, up sequentially from $0.22 in Q3 2013. Two analysts surveyed by Capital IQ called for non-GAAP diluted EPS of $0.29. Revenue was down 2% from Q3 2013 to $134.6 million, falling short of the $140 million Capital IQ consensus. For Q1 2014, the company estimates revenues to be between … Continue reading Tower Semiconductor (NASDAQ:TSEM) Tops Street Forecasts; NYSE:TSL, NYSE:DE, NYSE:KSS

John Meady
Earnings

Morning Earnings Roundup: Delek, Assured Guaranty, American States

Energy company Delek US Holdings, Inc. (NYSE:DK) reported Wednesday night Q4 2013 net loss of $4.7 million, or $0.08 per share, compared to a net income of $64.3 million, or $1.06 per share, a year earlier. Adjusted earnings were not provided, which would have been comparable to the Capital IQ consensus of $0.11. Net sales totaled $1.9 billion, down from $2.2 billion last year, missing … Continue reading Morning Earnings Roundup: Delek, Assured Guaranty, American States

John Meady